Fused heterocyclic compounds
AssigneeTakeda Pharmaceutical Company Limited
InventorsSatoru Oi, Koji Ikedou, Koji Takeuchi, Masaki Ogino, Yoshihiro Banno, Hiroyuki Tawada, Taihei Yamane
Life of this patent
Estimating the term…
Loading patent…
AssigneeTakeda Pharmaceutical Company Limited
InventorsSatoru Oi, Koji Ikedou, Koji Takeuchi, Masaki Ogino, Yoshihiro Banno, Hiroyuki Tawada, Taihei Yamane
Estimating the term…
The present invention provides a compound of the formula: wherein ring A is an optionally substituted 5 to 10-membered aromatic ring; R1 and R2 are the same or different and each is an optionally substituted hydrocarbon group or an optionally substituted heterocyclic group; X is a bond and the like; and L is a divalent hydrocarbon group, and a salt thereof, except 3-(aminomethyl)-2,6,7-trimethyl-4-phenyl-1(2H)-isoquinolinone, 3-(aminomethyl)-2-methyl-4-phenyl-1(2H)-isoquinolinone, 3-(aminomethyl)-6-chloro-2-methyl-4-phenyl-1(2H)-isoquinolinone and 3-(aminomethyl)-2-isopropyl-4-phenyl-1(2H)-isoquinolinone. The compound shows a superior peptidase-inhibitory activity and is useful as an agent for the prophylaxis or treatment of diabetes and the like. 1
A compound of the formula
A crystal of 2-[3-(aminomethyl)-4-butoxy-2-isobutyl-1-oxo-1,2-dihydro-6-isoquinolyl]-1,3-thiazole-4-carbonitrile or a salt thereof.
A crystal of 2-[3-(aminomethyl)-4-butoxy-2-isobutyl-1-oxo-1,2-dihydro-6-isoquinolyl]-1,3-thiazole-4-carboxamide or a salt thereof.
A crystal of 2-[3-(aminomethyl)-4-butoxy-2-isobutyl-1-oxo-1,2-dihydro-6-isoquinolyl]-1,3-thiazole-4-carboxamide or a salt thereof.
A crystal of ethyl 2-[3-(aminomethyl)-4-butoxy-2-isobutyl-1-oxo-1,2-dihydro-6-isoquinolyl]-1,3-thiazole-4-carboxylate or a salt thereof.
A crystal of (E)-3-[3-(aminomethyl)-4-butoxy-2-isobutyl-1-oxo-1,2-dihydro-6-isoquinolyl]-2-propenamide or a salt thereof.
A crystal of (E)-3-[3-(aminomethyl)-2-isobutyl-4-phenyl-1-oxo-1,2-dihydro-6-isoquinolyl]-2-propenamide or a salt thereof.
A crystal of 3-(aminomethyl)-2-isobutyl-1-oxo-4-phenyl-1,2-dihydro-6-isoquinolinecarboxamide or a salt thereof.
A crystal of 2-[[3-(aminomethyl)-2-isobutyl-4-phenyl-1-oxo-1,2-dihydro-6-isoquinolyl]oxy]acetamide or a salt thereof.
A pharmaceutical agent containing a compound of the formula
An agent for prophylaxis or treatment of diabetes, which contains a compound of the formula
An agent for prophylaxis or treatment of diabetic complications, which contains a compound of the formula
An agent for prophylaxis or treatment of impaired glucose tolerance, which contains a compound of the formula
An agent for prophylaxis or treatment of obesity, which contains a compound of the formula
A peptidase inhibitor containing a compound of the formula
A method of prophylaxis or treatment of diabetes in a mammal, which method comprising administering a compound of the formula
A method of prophylaxis or treatment of diabetic complications in a mammal, which method comprising administering a compound of the formula
A method of prophylaxis or treatment of impaired glucose tolerance in a mammal, which method comprising administering a compound of the formula
A method of prophylaxis or treatment of obesity in a mammal, which method comprising administering a compound of the formula
A method of inhibiting peptidase in a mammal, which method comprising administering a compound of the formula
Use of a compound of the formula
Use of a compound of the formula
Use of a compound of the formula
Use of a compound of the formula
Use of a compound of the formula
A production method of a compound of the formula
A compound of the formula
A compound of the formula
Dependencies are inferred from the claim text.